Please use this identifier to cite or link to this item: http://ir.juit.ac.in:8080/jspui/jspui/handle/123456789/9382
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSharma, Gaurav-
dc.contributor.authorNaushad, Mu.-
dc.contributor.authorThakur, Bharti-
dc.contributor.authorKumar, Amit-
dc.contributor.authorNegi, Poonam-
dc.contributor.authorSaini, Reena-
dc.contributor.authorChahal, Anterpreet-
dc.contributor.authorKumar, Ashok-
dc.contributor.authorStadler, Florian J.-
dc.contributor.authorAqil, U.M.H.-
dc.date.accessioned2023-01-24T06:14:39Z-
dc.date.available2023-01-24T06:14:39Z-
dc.date.issued2018-
dc.identifier.urihttp://ir.juit.ac.in:8080/jspui/jspui/handle/123456789/9382-
dc.description.abstractSodium dodecyl sulphate-supported iron silicophosphate (SDS/FeSP) nanocomposite was successfully fabricated by the co-precipitationmethod. The SDS/FeSP nanocompositewas investigated as a drug carrier for ondansetron. The cumulative drug release of ondansetron was observed at various pH values for different time intervals, i.e., from 20 min to 48 h. A ranking of the drug release was observed at different pHs; pH 2.2 > saline (pH 5.5) > pH 7.4 > pH 9.4 > distilled water. Maximum release of encapsulated drug was found to be about 45.38% at pH 2.2. The cell viability tests of SDS/FeSP nanocomposite concluded that SDS/FeSP nanocomposite was non-cytotoxic in nature.en_US
dc.language.isoenen_US
dc.publisherJaypee University of Information Technology, Solan, H.P.en_US
dc.subjectSodium dodecyl sulphateen_US
dc.subjectNanocompositeen_US
dc.subjectDrug deliveryen_US
dc.subjectOndansetronen_US
dc.titleSodium Dodecyl Sulphate-Supported Nanocomposite as Drug Carrier System for Controlled Delivery of Ondansetronen_US
dc.typeArticleen_US
Appears in Collections:Journal Articles



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.